Detalhe da pesquisa
1.
GTSE1 expression represses apoptotic signaling and confers cisplatin resistance in gastric cancer cells.
BMC Cancer
; 15: 550, 2015 Jul 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-26209226
2.
RNA-Binding Protein ZFP36L1 Suppresses Hypoxia and Cell-Cycle Signaling.
Cancer Res
; 80(2): 219-233, 2020 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31551365
3.
FBXW5 Promotes Tumorigenesis and Metastasis in Gastric Cancer via Activation of the FAK-Src Signaling Pathway.
Cancers (Basel)
; 11(6)2019 Jun 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-31213005
4.
Anti-tumor efficacy of Selinexor (KPT-330) in gastric cancer is dependent on nuclear accumulation of p53 tumor suppressor.
Sci Rep
; 8(1): 12248, 2018 08 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-30115935
5.
ATM Expression Predicts Veliparib and Irinotecan Sensitivity in Gastric Cancer by Mediating P53-Independent Regulation of Cell Cycle and Apoptosis.
Mol Cancer Ther
; 15(12): 3087-3096, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27638859
6.
Melanoma associated antigen (MAGE)-A3 promotes cell proliferation and chemotherapeutic drug resistance in gastric cancer.
Cell Oncol (Dordr)
; 39(2): 175-86, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26868260
7.
Strategies and Advancements in Harnessing the Immune System for Gastric Cancer Immunotherapy.
J Immunol Res
; 2015: 308574, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26579545